Scroll to top
© 2020, Startuprecipe theme by Rssow

[StartupRecipe] Korea’s Startup Market Is Now Winner Takes All

#Weekly Funding Overview

[March.23~ March.27]

#FUNDING

CompanyInudustryAmountRoundInvestors
Miboo Heavy IndustriesShipbuilding / MRO12.2 billionIBKS Innovation Material/Parts/Equipment New Tech Investment Fund No. 4
Minish TechnologyTooth Restoration Solution30 billionVIG Partners
J-Innts BioBio18 billionSeries CYuhan Corporation
Anabatic SemiBMS Semi15 billionSeries BSmilegate Investment, Mirae Asset Venture Inv., JB Inv., IBK Bank, IM Investment Partners, Ecopro Partners
Labrador LabsSoftware Supply Chain Security14.5 billionSeries BShinhan Venture Investment, DS Asset Mgmt, POSCO Tech Investment, Stonebridge Ventures, Korea Asset, TK Investment., Novosec Investment
PlaifDual-arm Robots13.9 billionSeries APartners Investment, Woori Venture Partners, Stick Ventures
Pion ElectricNext-gen Energy Solution13 billionSeries BDoosan Investment, D3 Jubilee Partners, Samchully Asset Management / SKS PE
New Cancer Cure BioCancer Therapeutics5 billionIntervalue Partners, Dongyu Technology Investment, Astone Ventures, Kingo Investment Partners
MobilintAI Semiconductor Design4 billionSeries CCompany K Partners
MBD3D Cell Culture Platform4 billion
LPHYSIOPosture Mgmt Studio300 millionStar Asset Partners
KimuteDaily Beauty Solution-Heim Venture Investment
Jocoding AX PartnersAI Redesign Solution-Primer
Cellac BioBio-Aesthetics-The Founders
IRVISIndustrial Vision AI-Y&Archer
MTGMaterial & Adhesive Solution-Kingo Spring
Choice For WomenWomen's Wellness Underwear-M&AThe Future
FrefinsRental Conversion Fintech-Alantes Corporate Finance
THE GRIMM ENTERTAINMENTWebtoon Production-GrantScale-up TIPS

#TREND ANALYSIS

Korea’s Startup Market Is Now Winner Takes All
South Korea’s startup investment market is on track to exceed KRW 1.5 trillion in the first quarter of 2026, surpassing the same period last year, according to statistical data from Startup Recipe. But beneath the headline figures, a more troubling picture is emerging: funding for early-stage companies is drying up, while capital piles into later-stage businesses with validated models — widening a divide that is pushing the so-called “valley of death” deeper than ever.

Quarterly investment opened at KRW 375 billion in January, surged to a quarterly peak of KRW 697.9 billion in February, and has held above the KRW 400 billion mark in March, sustaining an upward trajectory on the surface. Stage-by-stage data, however, tells a starkly different story.

The most alarming signal is the rapid contraction of seed and pre-Series A investment — the stages that sustain startups before they reach stable growth. Seed-stage deals, which accounted for 22% of total investment activity in January, slipped to 20% by March. More striking is the collapse of pre-Series A funding, which serves as a critical bridge for early-stage companies before they can access larger rounds. Its share plummeted from 15% in January to just 4% in February, recovering only modestly to around 5% in March — shrinking to roughly one-third of its January level within a single quarter. The data signals that the gateway between early-stage founding and the next round of financing has grown significantly narrower, leaving a growing number of founding teams exposed to acute funding shortfalls.

On the other end of the spectrum, growth-stage investment has expanded sharply. Mid-to-late stage deals — spanning Series B through pre-IPO rounds — represented just 5% of investment activity in January, before surging nearly fourfold to approximately 19% in February and holding at around 17% in March, cementing their place as a market mainstream.

The trend was underscored by a series of large-ticket transactions. In February, SmartScore closed a 110 billion KRW pre-IPO round — one of the quarter’s most significant deals. March saw Autonomous A2Z secure 40.5 billion KRW, further illustrating the concentration of substantial capital in a small number of late-stage companies.

The late-stage capital surge has been most pronounced in bio and deep tech. In biotech, Ellicigen led the way in January with a KRW 42 billion Series C raise, followed in March by Must Bio (KRW 35 billion, Series C), Minish Technology (KRW 30 billion), and Ticaros (KRW 20.8 billion, Series D). On the deep tech side, autonomous driving firm Autonomous A2Z’s 40.5 billion KRW pre-IPO raise and robotics solutions company Twinny’s KRW 20.4 billion Series C were confirmed in March, with a handful of technically advanced, late-stage companies absorbing a disproportionate share of total market capital.

The first quarter of 2026 has reinforced a winner-takes-all investment dynamic. Despite active early-stage activity — including batch recruiting by accelerators — the large sums required for genuine business growth flowed almost exclusively to companies at Series B and beyond. Series A investment share remained essentially flat, hovering between 8% and 9% throughout the quarter, while the pre-Series A funding cliff deepened further.

#MORE NEWS

sign up for Startup Recipe newsletter

Related News

Access to the latest Korean startup news and startup database for free

sign up for Startup Recipe newsletter